In the same study, systemic pharmacological inhibition of the IRE1α kinase activity using the small molecule inhibitor G9668 significantly improved anti-tumor responses and enhanced the effectiveness of anti-PD-L1 ICI in mouse BCa models [177]. Here, CD274 is linked to neoplasm.